文献速递痛风与晶体性关节病自身炎症与 IgG4 相关病

PPARGC1B基因变异增强NLRP3介导的痛风性关节炎炎症

Genetic variants of PPAR-gamma coactivator 1B augment NLRP3-mediated inflammation in gouty arthritis.
PubMed 文献 · Rheumatology (Oxford) · 2017-01-01

该研究在448例台湾汉族痛风患者与943例人群对照中筛查22个候选基因变异,发现PPARGC1B的错义单核苷酸多态性rs45520937与痛风显著相关(P=6.66×10⁻⁹,OR 1.85,95%CI 1.51–2.28)。功能实验显示,该风险A等位基因可上调NLRP3及血浆IL-1β表达,提示PPARGC1B变异参与痛风性关节炎的免疫代谢发病机制。

要点

  • PPARGC1B rs45520937与痛风显著相关,OR为1.85(95%CI 1.51–2.28)。
  • 风险A等位基因携带者NLRP3(P=0.044)与血浆IL-1β(P=0.006)升高。
  • PPARGC1B经NLRP3/IL-1β通路调控尿酸结晶诱导的炎症。

核心结论

  • PPARGC1B基因变异与痛风显著相关, rs45520937错义单核苷酸多态性可增强NLRP3和IL-1β表达,提示其参与痛风性关节炎发病机制。

研究设计与样本

  • 研究纳入台湾汉族448例痛风患者与943例人群对照,筛查22个候选基因变异,并通过复制与合并样本分析验证关联。
  • 功能实验采用定量PCR、ELISA、siRNA敲低与转染,在THP-1细胞、外周血单个核细胞及患者滑膜细胞中进行。

主要发现

  • 痛风性关节炎与PPARGC1B变异显著相关,包括错义单核苷酸多态性rs45520937(P=6.66×10⁻⁹;OR 1.85,95%CI 1.51–2.28)。
  • 尿酸结晶激活的THP-1细胞、外周血单个核细胞及急性期痛风患者滑膜细胞中PPARGC1B与NLRP3表达被诱导。
  • siRNA敲低PPARGC1B可上调尿酸结晶激活巨噬细胞中的NLRP3。
  • 携带rs45520937风险A等位基因的患者较野生型携带者NLRP3(P=0.044)与血浆IL-1β(P=0.006)升高。
  • 将携带rs45520937 A等位基因的PPARGC1B cDNA转染巨噬细胞可显著增强NLRP3与IL-1β表达。

关键数值与推荐

  • rs45520937与痛风关联:P=6.66×10⁻⁹;OR(95%CI)=1.85(1.51,2.28)。
  • 风险A等位基因携带者NLRP3比较:P=0.044;血浆IL-1β比较:P=0.006。

临床怎么用

  • 该发现提示PPARGC1B-NLRP3-IL-1β轴可能作为痛风性关节炎炎症调控的潜在靶点,rs45520937或有助于风险分层研究。

局限性

  • 研究人群为台湾汉族,结论外推至其他族群需谨慎;功能实验以体外细胞为主,尚需更多体内验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Gout is characterized by recurrent attacks of arthritis with hyperuricaemia and urate crystal-induced inflammation. Although urate transporters are known as risk factors, the immunogenetics of gouty inflammation remains unclear. This study aimed to investigate the genetic association between immune/metabolism regulators and gout. METHODS: We enrolled 448 gout patients and 943 population controls from Taiwan; all were Han Chinese. We screened association between gout and 22 variants of candidate genes, including NLRP3 , caspase 1, peroxisome proliferator-activated receptor-γ, proliferator-activated receptor-γ coactivator 1α ( PPARGC1A ) and 1β ( PPARGC1B ). The association was validated by replication and combined-sample analyses. Functional assays were performed by quantitative PCR, ELISA, siRNA knockdown and transfection using THP-1 cells, peripheral blood mononuclear cells and synovial cells from patients. RESULTS: Gouty arthritis exhibited significant association with variants of peroxisome PPARGC1B , which included a missense single nucleotide polymorphism, rs45520937 [P = 6.66 × 10 -9 ; odds ratio (95% CI): 1.85 (1.51, 2.28)]. Expression of PPARGC1B and NLRP3 was induced in urate crystal-activated THP-1, peripheral blood mononuclear cells and synovial cells from gout patients in acute stage. siRNA knockdown of PPARGC1B upregulated NLRP3 in urate crystal-activated macrophages. Compared with the wild-type carriers, patients with the risk A allele of rs45520937 showed statistically increased NLRP3 (P = 0.044) and plasma IL-1β (P = 0.006). Transfection of PPARGC1B cDNA with rs45520937 A allele to macrophages significantly augmented the expression of NLRP3 and IL-1β. CONCLUSION: Genetic variants of PPARGC1B are significantly associated with gout, and a missense single nucleotide polymorphism, rs45520937, augments NLRP3 and IL-1β expression. These data suggest that variants of PPARGC1B , a regulator of metabolism and inflammation, contribute to the pathogenesis of gouty arthritis.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Chang WC, Jan Wu YJ, Chung WH, et al. Genetic variants of PPAR-gamma coactivator 1B augment NLRP3-mediated inflammation in gouty arthritis. Rheumatology (Oxford). 2017. PMID: 28394398. doi:10.1093/rheumatology/kew337

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。